Veterinary Drug Market To Reach $85.0 Billion by 2035

Veterinary drug market is projected to grow from $50.0 billion in 2025 to $85.0 billion by 2035, expanding at a CAGR of 6.3% during the forecast period. The market growth is primarily driven by the rising demand for animal protein and increasing focus on animal health management across both livestock and companion animal segments. Among product types, Vaccines represent the fastest-growing segment due to increasing emphasis on preventive healthcare over curative treatments. The shift toward biologics is supported by regulatory restrictions on antibiotic usage in livestock and growing awareness regarding antimicrobial resistance.

Browse the full report description of “Veterinary Drug Market Size, Share & Trends Analysis Report, By Product Type (Anti-infectives, Anti-Inflammatory, Parasiticides, Vaccines, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce/Online Pharmacies, Farm & Agricultural Supply Stores), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/pet-veterinary-drug-market

Additionally, zoonotic disease prevention and food safety regulations are intensifying globally. Some years ago, the World Health Organization highlighted that over 60% of infectious diseases in humans are zoonotic in origin, emphasizing the critical role of veterinary medicines in controlling disease transmission. Governments are implementing stricter vaccination and treatment protocols, especially in developing economies, further accelerating market growth.

Competitive Landscape

Key companies operating in the global veterinary drug market include Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Merck & Co., Inc., Zoetis Inc., and Others. Players are also focusing on strategic partnerships, acquisitions, and geographic expansion to strengthen their global footprint and product portfolios.

Recent Developments

• In November 2025, Boehringer Ingelheim International GmbH announced that its avian influenza vaccines VAXXITEK HVT+IBD+H5 and VAXXINACT H5 received positive opinions from the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP). The development supports the company’s strategy to expand its vaccine portfolio for poultry disease prevention and strengthen its position in the veterinary biologics market.

• In June 2025, Zoetis Inc. launched AI Masses, an artificial intelligence-powered cytology capability for its Vetscan Imagyst® platform. The solution enables rapid detection and classification of skin and lymph node lesions in animals, improving diagnostic accuracy and supporting faster clinical decision-making in veterinary medicine.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Route of Administration
  • By Distribution Channel

Competitive Landscape – Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Merck & Co., Inc., Zoetis Inc., and Others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Veterinary Drug Market Report Segment

By Product Type

• Anti-infectives
• Anti-Inflammatory
• Parasiticides
• Vaccines
• Others

By Route of Administration

• Oral
• Injectable
• Topical
• Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• E-commerce / Online Pharmacies
• Farm & Agricultural Supply Stores

Global Veterinary Drug Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pet-veterinary-drug-market